| Literature DB >> 32562943 |
Takaichi Watanabe1, Teru Okitsu1, Fumisato Ozawa1, Shogo Nagata1, Hitomi Matsunari2, Hiroshi Nagashima3, Masaki Nagaya2, Hiroki Teramae1, Shoji Takeuchi4.
Abstract
Transplantation technologies of pancreatic islets as well as stem cell-derived pancreatic beta cells encapsulated in hydrogel for the induction of immunoprotection could advance to treat type 1 diabetes mellitus, if the hydrogel transplants acquire retrievability through mitigating foreign body reactions after transplantation. Here, we demonstrate that the diameter of the fiber-shaped hydrogel transplants determines both in vivo cellular deposition onto themselves and their retrievability. Specifically, we found that the in vivo cellular deposition is significantly mitigated when the diameter is 1.0 mm and larger, and that 1.0 mm-thick xenoislet-laden fiber-shaped hydrogel transplants can be retrieved after being placed in the intraperitoneal cavities of immunocompetent diabetic mice for more than 100 days, during which period the hydrogel transplants can normalize the blood glucose concentrations of the mice. These findings could provide an innovative concept of a transplant that would promote the clinical application of stem cell-derived functional cells through improving their in vivo efficacy and safety.Entities:
Keywords: Alginate; Immunoprotection; Islet encapsulation; Regenerative medicine; Retrievable graft; Xenotransplantation
Mesh:
Substances:
Year: 2020 PMID: 32562943 DOI: 10.1016/j.biomaterials.2020.120162
Source DB: PubMed Journal: Biomaterials ISSN: 0142-9612 Impact factor: 12.479